Evergreen Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.1M | Sell |
51,916
-4,819
| -8% | -$1.04M | 0.23% | 98 |
|
|
2026
Q1 | $12.3M | Buy |
56,735
+2,360
| +4% | +$524K | 0.27% | 90 |
|
|
2025
Q4 | $12.4M | Buy |
54,375
+1,797
| +3% | +$409K | 0.28% | 90 |
|
|
2025
Q3 | $12.2M | Buy |
52,578
+3,178
| +6% | +$647K | 0.29% | 87 |
|
|
2025
Q2 | $9.17M | Buy |
49,400
+703
| +1% | +$131K | 0.28% | 98 |
|
|
2025
Q1 | $10.2M | Sell |
48,697
-8,915
| -15% | -$1.73M | 0.34% | 79 |
|
|
2024
Q4 | $10.2M | Buy |
57,612
+2,099
| +4% | +$386K | 0.33% | 84 |
|
|
2024
Q3 | $11M | Buy |
55,513
+1,563
| +3% | +$292K | 0.37% | 71 |
|
|
2024
Q2 | $9.25M | Sell |
53,950
-12
| -0% | -$1.99K | 0.33% | 82 |
|
|
2024
Q1 | $9.83M | Sell |
53,962
-11,484
| -18% | -$1.98M | 0.37% | 71 |
|
|
2023
Q4 | $10.1M | Buy |
65,446
+2,432
| +4% | +$355K | 0.41% | 70 |
|
|
2023
Q3 | $9.39M | Buy |
63,014
+4,829
| +8% | +$709K | 0.41% | 67 |
|
|
2023
Q2 | $7.84M | Sell |
58,185
-3,445
| -6% | -$505K | 0.33% | 90 |
|
|
2023
Q1 | $9.82M | Buy |
61,630
+1,672
| +3% | +$256K | 0.44% | 63 |
|
|
2022
Q4 | $9.69M | Buy |
59,958
+976
| +2% | +$150K | 0.46% | 63 |
|
|
2022
Q3 | $7.92M | Buy |
58,982
+4,185
| +8% | +$601K | 0.41% | 67 |
|
|
2022
Q2 | $8.39M | Sell |
54,797
-3,577
| -6% | -$547K | 0.44% | 67 |
|
|
2022
Q1 | $9.46M | Sell |
58,374
-3,377
| -5% | -$491K | 0.39% | 76 |
|
|
2021
Q4 | $8.36M | Buy |
61,751
+7,877
| +15% | +$930K | 0.33% | 85 |
|
|
2021
Q3 | $5.81M | Buy |
53,874
+6,436
| +14% | +$735K | 0.26% | 101 |
|
|
2021
Q2 | $5.34M | Buy |
47,438
+3,054
| +7% | +$344K | 0.26% | 101 |
|
|
2021
Q1 | $4.8M | Buy |
44,384
+6,885
| +18% | +$736K | 0.25% | 106 |
|
|
2020
Q4 | $4.02M | Buy |
37,499
+5,600
| +18% | +$538K | 0.23% | 104 |
|
|
2020
Q3 | $2.79M | Buy |
31,899
+2,302
| +8% | +$217K | 0.19% | 122 |
|
|
2020
Q2 | $2.91M | Buy |
29,597
+4,486
| +18% | +$395K | 0.22% | 108 |
|
|
2020
Q1 | $1.91M | Buy |
25,111
+13,608
| +118% | +$1.16M | 0.18% | 113 |
|
|
2019
Q4 | $1.02M | Buy |
11,503
+4,356
| +61% | +$362K | 0.08% | 172 |
|
|
2019
Q3 | $541K | Sell |
7,147
-1,561
| -18% | -$107K | 0.05% | 218 |
|
|
2019
Q2 | $633K | Sell |
8,708
-15
| -0.2% | -$1.18K | 0.06% | 198 |
|
|
2019
Q1 | $703K | Sell |
8,723
-181
| -2% | -$14.8K | 0.07% | 181 |
|
|
2018
Q4 | $821K | Buy |
8,904
+739
| +9% | +$65K | 0.09% | 169 |
|
|
2018
Q3 | $772K | Sell |
8,165
-65
| -0.8% | -$6.16K | 0.07% | 188 |
|
|
2018
Q2 | $763K | Sell |
8,230
-32
| -0.4% | -$3.13K | 0.07% | 174 |
|
|
2018
Q1 | $782K | Buy |
8,262
+2,178
| +36% | +$239K | 0.08% | 164 |
|
|
2017
Q4 | $588K | Buy |
+6,084
| New | +$573K | 0.06% | 168 |
|
|
2017
Q3 | – | Sell |
-4,420
| Closed | -$320K | – | 181 |
|
|
2017
Q2 | $320K | Buy |
4,420
+725
| +20% | +$48.7K | 0.05% | 116 |
|
|
2017
Q1 | $241K | Sell |
3,695
-434
| -11% | -$27.3K | 0.05% | 95 |
|
|
2016
Q4 | $259K | Sell |
4,129
-66
| -2% | -$4.03K | 0.05% | 104 |
|
|
2016
Q3 | $265K | Hold |
4,195
| – | – | 0.05% | 96 |
|
|
2016
Q2 | $260K | Hold |
4,195
| – | – | 0.06% | 91 |
|
|
2016
Q1 | $240K | Hold |
4,195
| – | – | 0.06% | 83 |
|
|
2015
Q4 | $249K | Sell |
4,195
-400
| -9% | -$23K | 0.06% | 85 |
|
|
2015
Q3 | $250K | Buy |
4,595
+500
| +12% | +$32.5K | 0.06% | 79 |
|
|
2015
Q2 | $275K | Hold |
4,095
| – | – | 0.07% | 80 |
|
|
2015
Q1 | $239K | Sell |
4,095
-770
| -16% | -$46.5K | 0.05% | 96 |
|
|
2014
Q4 | $281K | Sell |
4,865
-400
| -8% | -$25.2K | 0.06% | 88 |
|
|
2014
Q3 | $304K | Buy |
5,265
+700
| +15% | +$38.9K | 0.06% | 85 |
|
|
2014
Q2 | $258K | Sell |
4,565
-700
| -13% | -$36.7K | 0.05% | 94 |
|
|
2014
Q1 | $271K | Hold |
5,265
| – | – | 0.05% | 87 |
|
|
2013
Q4 | $278K | Sell |
5,265
-700
| -12% | -$34.4K | 0.05% | 94 |
|
|
2013
Q3 | $267K | Buy |
5,965
+700
| +13% | +$31K | 0.04% | 109 |
|
|
2013
Q2 | $218K | Buy |
+5,265
| New | +$230K | 0.03% | 116 |
|
Other funds holding ABBV
Evergreen Capital Management's ABBV Position: Q2 2026 in Review
Evergreen Capital Management reduced its AbbVie (ABBV) stake by 8.5% in Q2 2026, selling an estimated $1.04M and leaving 51,916 shares worth $13.1M. The position accounts for 0.23% of the portfolio, ranked #98.
Evergreen Capital Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Evergreen Capital Management held 51,916 shares of AbbVie worth $13.1M as of Q2 2026.
- Evergreen Capital Management sold 4,819 AbbVie shares in Q2 2026, an estimated $1.04M.
- AbbVie made up 0.23% of Evergreen Capital Management's portfolio in Q2 2026, its #98 holding.
- Evergreen Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.